L’évolution de la technique opératoire fait de l'urétéroscopie souple –Laser (URSS-L) une méthode efficace et sure dans le traitement des calculs du haut appareil urinaire (HAU). Elle apparait comme une option salvatrice après échec des autres options thérapeutiques. Son coût limite son accessibilité et restreint ses indications dans certains contextes socio-économiques. Nous rapportons l'expérience du service sur les indications, les résultats et les complications de l'URSS-L dans le traitement des calculs du HAU. C'est une étude rétrospective sur 4ans concernant 130 patients ayant des calculs du HAU. Un scanner permettait de déterminer les caractéristiques des calculs avant l'intervention et de faire un contrôle après afin de juger de l'efficacité du traitement. Une analyse statistique évaluait l'influence des différents paramètres des calculs sur l'efficacité de l'intervention. Un suivi était réalisé afin de détecter les complications. L’âge moyen des patients était de 52 ± 17ans. 166 interventions étaient faites en 3 séries. Les indications étaient de première intention dans 50.32% suivi des échecs de LEC. La durée moyenne de l'intervention était de 73min ± 25min pour une taille moyenne des calculs de 13.78mm ± 5mm. Le taux de succès global était de 78.91% (78.71%; 80%; 100%) respectivement après la 1ère, la 2ème et la 3ème série. Aucun paramètre n'influençait significativement le taux de succès. 14.45% de complications était enregistré. L'URSS-L est une méthode aussi efficace que sure dans le traitement des calculs du HAU nous motivant malgré son coût, à élargir ses indications en première intention lorsque les calculs répondent aux critères de choix.

Background: Ultrasound is the main method of exploring the prostate. In benign prostatic hyperplasia (BPH), it provides important morphological information and assesses its impact, helping to guide the treatment. Objective: To compare intravesical prostatic protrusion (IPP) and middle lobe volume by ultrasound in BPH. Method: This was a single center prospective, descriptive and analytical study, over a period of 6 months, including 95 patients, undergoing prostatic trans-abdominal ultrasound. Patients were selected by a single urologist for clinical suspicion of benign prostatic hypertrophy. The ultrasound examination was done by a single senior radiologist. Results: The mean age of the patients was 66.63 ± 11.55 years with ranges from 38 to 98 years. The prevalence of BPH was 76.84%. The rate of patient with middle lobe protrusion was 48.42%. The mean middle lobe volume was 11.29 ± 12.90 ml. More than half of the patients (50.91%) had an IPP stage 3 of. The mean bladder wall thickness was 6.08 ± 2.58 mm, with 50.53% being pathological. The post-voiding residue (PVR) was significant in 38.75% of patients. Renal repercussions were present in 17.89%. The correlation analysis did not note a statistical link between prostate volume and quality of life score (p > 0.05). There was a statistically significant correlation between IPP values and quality of life score (p = 00461), IPSS score (p = 0.0424) and PVR (p = 0.0395). For middle lobe volume, there was a correlation with PVR (p = 0.0018). There was no correlation with clinical impact (quality of life score and IPSS score). Conclusion:

No abstract

No abstract

Background: Diagnosis of prostate cancer is certified by histology true prostate biopsies. The aim of our study was to evaluate our prostate biopsy method. Material and Methods: It was a prospective study including patients underwent prostate biopsy. Inclusion criteria were prostate specific antigen (PSA) level up to 4ng/ml and/or abnormal prostate at digital rectal examination. Patients who had risk factors of bleeding have been excluded of the study. The preparation before biopsy included antibioprophylaxy (Ciprofloxacine-Tinidazole) and rectal hypertonic cleaning (Normacol*). Twelve cores have been taken in each prostate by transrectal digital-guided way, using Biopty Gun 18 Gauge. Local anesthesia has been done previously by intrarectal application of 20 ml of gel of Lidocaïne. Two other cores were taken into each abnormal area at rectal examination. The follow-up have been done during twelve weeks. Results: Eighty patients of 65 years of age were included. Nine patients had familial history of prostate cancer. PSA levels ranged from 5 to 6400 ng/ml with a median of 26.77 ng/ml ± 11.2. Complications occurred in 11.25% of patients, principally infectious complications which caused death of one patient by septicemia. The rate of cancer detection was 20%. Prostate abnormality at digital rectal examination and the presence of familial history of prostate cancer were not predictive factors of the presence of cancer on cores. Conclusion: Our prostate biopsy method is limited by the lack of ultrasonographic guidance and is at important risk of infectious complications.